The Australian research, which aims to help people with motor neuron disease keep moving, is now testing AI to personalise assistance.

The partnership comes three months after Thyme Care raised $97 million in funding, bringing its total raise to $275 million.

ADP participated as a new investor in Thatch's $40 million Series B funding round in April, which brought the company's total ...

HEYDOC CEO Dr Raymond Choy explains how digital-first workflows can shoulder most care needs of small business employees, ...

The Order says it revokes attempts to paralyze the AI industry and establishes an AI Litigation Task Force to challenge State ...

The company will use the funds to advance product innovation, strengthen clinical partnerships and accelerate its nationwide ...

Investors are funneling capital into early-stage automation and clinical support tools that use AI to counter workforce ...

The LLM-based tool, developed by researchers from Yonsei University College of Medicine, automatically generates legally ...

Genentech will leverage Medra's Physical AI, Scientific AI and robotics into its lab systems to accelerate drug discovery.

Respiree is also preparing to file for regulatory approval for its AI tool in the United States and across Australia, New ...

CLEAR's biometric ID verification will be added to Welldoc's cardiometabolic care app, a move the companies say supports ...